Deepak Raghavan, Ph.D. - Publications

Affiliations: 
2009 Georgia State University, Atlanta, GA, United States 
Area:
Astronomy and Astrophysics

13/219 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Mason BD, Hartkopf WI, Miles KN, Subasavage JP, Raghavan D, Henry TJ. Speckle Interferometry of Red Dwarf Stars The Astronomical Journal. 155: 215. DOI: 10.3847/1538-3881/Aab9B8  0.508
2016 Richardson ND, Moffat AFJ, Maltais-Tariant R, Pablo H, Gies DR, Saio H, St-Louis N, Schaefer G, Miroshnichenko AS, Farrington C, Aldoretta EJ, Artigau É, Boyajian TS, Gordon K, Jones J, ... ... Raghavan D, et al. Spectroscopy, MOST photometry, and interferometry of MWC 314: Is it an LBV or an interacting binary? Monthly Notices of the Royal Astronomical Society. 455: 244-257. DOI: 10.1093/Mnras/Stv2291  0.751
2014 Richardson ND, Moffat AFJ, Maltais-Tariant R, Pablo H, Gies DR, St-Louis N, Schaefer G, Miroshnichenko AS, Farrington C, Aldoretta EJ, Artigau É, Boyajian T, Gordon K, Goldfinger PJ, Jones J, ... ... Raghavan D, et al. MWC 314: Binary results from optical interferometry compared with spectroscopy and photometry Proceedings of Spie - the International Society For Optical Engineering. 9146. DOI: 10.1117/12.2055364  0.744
2012 Raghavan D, Farrington CD, Ten Brummelaar TA, McAlister HA, Ridgway ST, Sturmann L, Sturmann J, Turner NH. A search for separated fringe packet binaries using the CHARA array Astrophysical Journal. 745. DOI: 10.1088/0004-637X/745/1/24  0.733
2011 O'Brien DP, McAlister HA, Raghavan D, Boyajian TS, Ten Brummelaar TA, Sturmann J, Sturmann L, Turner NH, Ridgway S. Inner orbits in hierarchical triple systems from the CHARA Array. I. V819 Her B Astrophysical Journal. 728. DOI: 10.1088/0004-637X/728/2/111  0.713
2011 Mason BD, Hartkopf WI, Raghavan D, Subasavage JP, Roberts LC, Turner NH, Ten Brummelaar TA. Know the star, know the planet. II. Speckle interferometry of exoplanet host stars Astronomical Journal. 142. DOI: 10.1088/0004-6256/142/5/176  0.495
2010 Raghavan D, McAlister HA, Henry TJ, Latham DW, Marcy GW, Mason BD, Gies DR, White RJ, Ten Brummelaar TA. A survey of stellar families: Multiplicity of solar-type stars Astrophysical Journal, Supplement Series. 190: 1-42. DOI: 10.1088/0067-0049/190/1/1  0.704
2010 Farrington CD, Ten Brummelaar TA, Mason BD, Hartkopf WI, McAlister HA, Raghavan D, Turner NH, Sturmann L, Sturmann J, Ridgway ST. Separated fringe packet observations with the CHARA array. I. Methods and new orbits for χ Draconis, HD 184467, and HD 198084 Astronomical Journal. 139: 2308-2318. DOI: 10.1088/0004-6256/139/6/2308  0.694
2009 Raghavan D, McAlister HA, Torres G, Latham DW, Mason BD, Boyajian TS, Baines EK, Williams SJ, Brummelaar TAT, Farrington CD, Ridgway ST, Sturmann L, Sturmann J, Turner NH. The visual orbit of the 1.1 day spectroscopic binary σ2 coronae borealis from interferometry at the chara array Astrophysical Journal. 690: 394-406. DOI: 10.1088/0004-637X/690/1/394  0.73
2008 Boyajian TS, McAlister HA, Baines EK, Gies DR, Henry T, Jao WC, O'Brien D, Raghavan D, Touhami Y, Ten Brummelaar TA, Farrington C, Goldfinger PJ, Sturmann L, Sturmann J, Turner NH, et al. Angular diameters of the G subdwarf μ Cassiopeiae A and the K dwarfs σ Draconis and HR 511 from interferometric measurements with the Chara array Astrophysical Journal. 683: 424-432. DOI: 10.1086/589554  0.707
2007 Grundstrom ED, Blair JL, Gies DR, Huang W, Mcswain MV, Raghavan D, Riddle RL, Subasavage JP, Wingert DW, Levine AM, Remillard RA. Joint Hα and X-ray observations of massive X-ray binaries. I. The B supergiant system LS 1 +65 010 = 2S 0114+650 Astrophysical Journal. 656: 431-436. DOI: 10.1086/510508  0.354
2006 Patten BM, Stauffer JR, Burrows A, Marengo M, Hora JL, Luhman KL, Sonnett SM, Henry TJ, Raghavan D, Megeath ST, Liebert J, Fazio GG. Spitzer IRAC photometry of M, L, and T dwarfs Astrophysical Journal. 651: 502-516. DOI: 10.1086/507264  0.434
2006 Raghavan D, Henry TJ, Mason BD, Subasavage JP, Jao WC, Beaulieu TD, Hambly NC. Two suns in the sky: Stellar multiplicity in exoplanet systems Astrophysical Journal. 646: 523-542. DOI: 10.1086/504823  0.529
Low-probability matches (unlikely to be authored by this person)
2014 Brendle J, Raghavan D. Bounding, splitting, and almost disjointness Annals of Pure and Applied Logic. 165: 631-651. DOI: 10.1016/j.apal.2013.09.002  0.122
2024 Sakthivel DK, Taur P, Paul R, Sundaram PM, Raghavan D. A decade's experience of robotic buccal ureteroplasty for post-ureteroscopic laser lithotripsy-induced strictures-Should this be the new standard? Asian Journal of Urology. 12: 258-261. PMID 40458572 DOI: 10.1016/j.ajur.2024.03.003  0.12
2012 Raghavan D, Steinberg M, Sandler H. Neutron radiotherapy in South Africa: Neutron radiotherapy: Abratt supported South African Medical Journal. 102: 271. PMID 22554324  0.115
2015 Raghavan D, Sandler HM. Invasive bladder cancer: Combined modality treatment Urological Oncology. 591-608. DOI: 10.1007/978-0-85729-482-1_34  0.109
2023 Raghavan D, Kannan D, Sekaran PG, Thangarasu M, J SP, Paul R, Taur P. A Novel Technique of Renorrhaphy in Difficult Partial Nephrectomies by Single-Layered Parenchymal Imbrication. Cureus. 15: e42702. PMID 37654940 DOI: 10.7759/cureus.42702  0.106
2012 Raghavan D, Todorcevic S. Cofinal types of ultrafilters Annals of Pure and Applied Logic. 163: 185-199. DOI: 10.1016/J.Apal.2011.08.002  0.104
2007 Raghavan D. Proudly presenting COLOURAGE... yet again Colourage. 54: 26+28.  0.101
2021 Raghavan D, Thangarasu M, J SP, Paul R, Selvaraj N. A Hemostatic Technique in Robot-Assisted Laparoscopic Partial Nephrectomy and Its Impact on Renal Function. Cureus. 13: e15122. PMID 34159024 DOI: 10.7759/cureus.15122  0.094
2003 Raghavan D. Progress in the chemotherapy of metastatic cancer of the urinary tract Cancer. 97: 2050-2055. PMID 12673696  0.093
1981 Selby P, Raghavan D. Role of laboratory chemosensitivity testing in the selection of cancer chemotherapy for individual patients Journal of Clinical Pathology. 34: 455-463. PMID 7019254  0.09
1985 Pearson BS, Raghavan D. First-line intravenous cisplatin for deeply invasive bladder cancer: Update on 70 cases British Journal of Urology. 57: 690-693. PMID 4084727  0.089
2008 Raghavan D. Functionalized clay vinyl ester nanocomposites Materials Research Society Symposium Proceedings. 1137: 197-202.  0.088
1990 Raghavan D, Rogers J. Update in the management of prostate cancer Medical Journal of Australia. 152: 419-426. PMID 2184331  0.086
2005 Balakrishnan S, Raghavan D. Chemically functionalized clay-epoxy nanocomposites: Vernonia oil-based surfactant Journal of Reinforced Plastics and Composites. 24: 785-793. DOI: 10.1177/0731684405047766  0.085
2010 Shepard DR, Raghavan D. Innovations in the systemic therapy of prostate cancer Nature Reviews Clinical Oncology. 7: 13-21. PMID 19997075 DOI: 10.1038/nrclinonc.2009.187  0.084
1990 Grant AJ, Russell PJ, Raghavan D. Active and pro-plasminogen activator on the surface of human bladder cancer cells derived from a high grade invasive tumour. Biochemical and Biophysical Research Communications. 172: 870-6. PMID 2173583 DOI: 10.1016/0006-291X(90)90756-D  0.083
2003 Balakrishnan S, Raghavan D. Chemically functionalized clay epoxy nanocomposites for aerospace applications 2003 Nanotechnology Conference and Trade Show - Nanotech 2003. 3: 250-253.  0.081
2008 Choueiri TK, Raghavan D. Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: Persisting uncertainties Nature Clinical Practice Oncology. 5: 444-454. PMID 18577983 DOI: 10.1038/ncponc1159  0.081
2002 Emekalam A, Gu X, Raghavan D. Characterization of renewable composites Materials Research Society Symposium - Proceedings. 702: 247-252. DOI: 10.1557/Proc-702-U7.1.1  0.08
2006 Raghavan D. Ushering in a new era of consumerism Colourage. 53.  0.08
1988 Raghavan D. Non-hormone chemotherapy for prostate cancer: Principles of treatment and application to the testing of new drugs Seminars in Oncology. 15: 371-389. PMID 3043671  0.08
1995 Raghavan D, Huben R. Management of bladder cancer Current Problems in Cancer. 19: 1-64. PMID 7768113 DOI: 10.1016/S0147-0272(07)80002-X  0.08
2004 Raghavan D, Skinner E. Genitourinary Cancer in the Elderly Seminars in Oncology. 31: 249-263. PMID 15112154 DOI: 10.1053/j.seminoncol.2003.12.034  0.08
2010 Raghavan D. Almost disjoint families and diagonalizations of length continuum Bulletin of Symbolic Logic. 16: 240-260.  0.079
2020 Ragavan N, Selvaraj N, Raghavan D, Kamalakannan R, Govindaswamy TG, Balakrishnan AK, Jain N. Robot Assisted Laparoscopic Adrenalectomy: Does Size Matter? Cureus. 12: e9887. PMID 32968553 DOI: 10.7759/cureus.9887  0.079
2007 Raghavan D. We have a new sibling.. Colourage. 54: 24+26.  0.077
2003 Raghavan D. Chemotherapy and cystectomy for invasive transitional cell carcinoma of bladder Urologic Oncology: Seminars and Original Investigations. 21: 468-474. PMID 14693275 DOI: 10.1016/S1078-1439(03)00145-5  0.077
1997 Huynh H, Raghavan D. Durability of simulated shredded rubber tire in highly alkaline environments Advanced Cement Based Materials. 6: 138-143. DOI: 10.1016/S1065-7355(97)81597-0  0.076
2007 Raghavan D. A matter of pride.. Colourage. 54: 28.  0.076
2015 Damodharan S, Raghavan D. Combining tissue segmentation and neural network for brain tumor detection International Arab Journal of Information Technology. 12: 42-52.  0.076
2000 Raghavan D. Advanced bladder and urothelial cancers European Journal of Cancer. 36. PMID 10908841 DOI: 10.1016/S0959-8049(00)00275-6  0.076
2000 Parimoo D, Raghavan D. Progress in the management of metastatic bladder cancer Cancer Control. 7: 347-356. PMID 10895129  0.075
2008 Raghavan D, Sandler HM. Multidisciplinary care of invasive bladder cancer: Emerging roles of chemotherapy Urological Oncology. 361-376. DOI: 10.1007/978-1-84628-738-1_20  0.075
2009 Kunen K, Raghavan D. Gregory trees, the continuum, and martin's axiom Journal of Symbolic Logic. 74: 712-720. DOI: 10.2178/Jsl/1243948337  0.074
2014 Raghavan D, Khan S. Use of Otoacoustic Emissions (OAE) to detect sub-clinical inner ear damage in divers of the Indian Navy. Medical Journal, Armed Forces India. 70: 344-8. PMID 25382908 DOI: 10.1016/j.mjafi.2014.04.004  0.073
1992 Raghavan D, Russell PJ, Brown JL. Experimental models of histogenesis and tumor cell heterogeneity in bladder cancer. Seminars in Surgical Oncology. 8: 279-84. PMID 1462098 DOI: 10.1002/ssu.2980080506  0.072
2007 Raghavan D. Auxiliaries... A new option for dyestuff manufacturers Colourage. 54: 26+28.  0.072
2010 Brawley OW, Newman LA, Raghavan D. Reply to M. Moore et al Journal of Clinical Oncology. 28: e38. DOI: 10.1200/JCO.2009.25.2908  0.072
2015 Sekar A, Raghavan D. Implementation of single phase soft switched PFC converter for Plug-in-Hybrid Electric Vehicles Energies. 8: 13096-13111. DOI: 10.3390/en81112361  0.072
2016 Raghavan D. Systemic Therapy for Invasive Bladder Cancer: The Value Proposition. The Oncologist. PMID 27125752 DOI: 10.1634/theoncologist.2016-0074  0.07
1980 Raghavan D, Barrett A. Mediastinal seminomas Cancer. 46: 1187-1191. PMID 7214301  0.069
2015 Frenette G, Raghavan D. Principles of chemotherapy for genitourinary cancer Urological Oncology. 277-297. DOI: 10.1007/978-0-85729-482-1_13  0.069
2012 Raghavan D, Steprans J. On weakly tight families Canadian Journal of Mathematics. 64: 1378-1394. DOI: 10.4153/CJM-2012-017-8  0.068
1988 Raghavan D, Grundy R, Lancaster L. Assessment of quality of life in long-term survivors treated by first-line intravenous cisplatin for invasive bladder cancer Progress in Clinical and Biological Research. 260: 625-631. PMID 3362911  0.068
2014 Raghavan D, Yorioka T. Suslin Lattices Order. 31: 55-79. DOI: 10.1007/s11083-013-9288-2  0.068
2009 Lindner D, Raghavan D. Intra-tumoural extra-cellular pH: A useful parameter of response to chemotherapy in syngeneic tumour lines British Journal of Cancer. 100: 1287-1291. PMID 19367285 DOI: 10.1038/sj.bjc.6605022  0.068
2014 Raghavan D, Todorcevic S. Combinatorial dichotomies and cardinal invariants Mathematical Research Letters. 21: 379-401. DOI: 10.4310/Mrl.2014.V21.N2.A13  0.067
2012 Burgess EF, Raghavan D. Prostate cancer: What did we learn from the 2012 annual scientific meeting of ASCO? Oncology (United States). 26.  0.067
2012 Burgess EF, Raghavan D. Prostate cancer: What did we learn from the 2012 annual scientific meeting of ASCO? Oncology (United States). 26.  0.067
2005 Balakrishnan S, Raghavan D. Chemically functionalized clay vinyl ester nanocomposites II vernonia oil-based surfactant Journal of Reinforced Plastics and Composites. 24: 5-20. DOI: 10.1177/0731684405041712  0.067
2003 Balakrishnan S, Raghavan D. Synthesis of 13(14)-hydroxy-cis-10-nonadecenyl amine hydrochloride Jaocs, Journal of the American Oil Chemists' Society. 80: 503-508.  0.066
2004 Raghavan D. Clinical problems in advanced bladder cancer Journal of B.U.On.. 9: 121-126.  0.066
2010 Raghavan D. Bladder cancer: Optimal application of preclinical models to suitable translational questions Science Translational Medicine. 2: 22ps11. PMID 20374999 DOI: 10.1126/scitranslmed.3000215  0.065
1991 Raghavan D. Keynote address: A critical assessment of trials of neoadjuvant (preemptive) chemotherapy for bladder cancer: Lesson for future studies of combined modality treatment International Journal of Radiation Oncology, Biology, Physics. 20: 233-237. PMID 1991684 DOI: 10.1016/0360-3016(91)90096-M  0.065
1996 Glaves D, Murray MK, Raghavan D. Novel bifunctional anthracycline and nitrosourea chemotherapy for human bladder cancer: Analysis in a preclinical survival model Clinical Cancer Research. 2: 1315-1319. PMID 9816302  0.063
2006 Raghavan D. Establishing the Colourage Centre of Excellence (COLOURAGE CoE) Colourage. 53.  0.062
2006 Raghavan D. An investigation of the influence of interface chemical structure on fiber/matrix adhesion Materials Research Society Symposium Proceedings. 977: 132-135.  0.061
2009 Raghavan D. Maximal almost disjoint families of functions Fundamenta Mathematicae. 204: 241-282. DOI: 10.4064/fm204-3-3  0.061
1980 Norgaard-Pedersen B, Raghavan D. Germ cell tumours: A collaborative review Oncodevelopmental Biology and Medicine. 1: 327-358.  0.061
1989 Grant AJ, Russell PJ, Raghavan D. Elastase activities of human bladder cancer cell lines derived from high grade invasive tumours. Biochemical and Biophysical Research Communications. 162: 308-15. PMID 2751654 DOI: 10.1016/0006-291X(89)91997-9  0.061
2015 Raghavan D. Big data: Not really the same as level 1 data Oncology (United States). 29. PMID 25592212  0.059
2020 Selvaraj N, Thangarasu M, Jayaprakash S, Raghavan D, Paul R. Bladder Neck Resection Combined with Ten Point Intralesional Mitomycin C Injection in Management of Refractory Bladder Neck Contracture in Post TURP Status: A Single-Center, 2-Year Experience. Research and Reports in Urology. 12: 433-438. PMID 33062622 DOI: 10.2147/RRU.S267561  0.059
2000 Raghavan D, Egwim K. Degradation of polyester film in alkali solution Journal of Applied Polymer Science. 78: 2454-2463. DOI: 10.1002/1097-4628(20001227)78:14<2454::Aid-App40>3.0.Co;2-9  0.059
1990 Raghavan D. Towards the earlier diagnosis of testicular cancer Australian Family Physician. 19: 865-875. PMID 2174237  0.059
2015 Raghavan D, Lee TC, Curtin HD. Cholesterol Granuloma of the Petrous Apex: A 5-Year Review of Radiology Reports with Follow-Up of Progression and Treatment. Journal of Neurological Surgery. Part B, Skull Base. 76: 266-71. PMID 26225314 DOI: 10.1055/s-0034-1396600  0.058
1992 Raghavan D, Wagner GC, Wool RP. Carbon balance during biodegradation of a polymer Polymeric Materials Science and Engineering, Proceedings of the Acs Division of Polymeric Materials Science and Engineering. 67: 357-358.  0.058
2010 Borden EC, Raghavan D. Personalizing medicine for cancer: The next decade Nature Reviews Drug Discovery. 9: 343-344. PMID 20431554 DOI: 10.1038/nrd3168  0.058
2015 Raghavan D. Point: Is cystectomy needed for small-cell bladder cancer? Oncology (United States). 29.  0.057
1992 Raghavan D. Management of advanced bladder cancer in the elderly Urologic Clinics of North America. 19: 797-806. PMID 1441033  0.057
2008 Raghavan D. Textile processing machinery: Think projects, not only components Colourage. 55: 30+32.  0.056
2013 Raghavan D. Invasive bladder cancer: Ignoring the data Oncologist. 18: 895-896. PMID 23986339 DOI: 10.1634/theoncologist.2013-0281  0.056
1981 Raghavan D. The applications of xenografts in the study of human germ cell tumours International Journal of Andrology. 4: 79-92.  0.055
2012 Raghavan D. A model with no strongly separable almost disjoint families Israel Journal of Mathematics. 189: 39-53. DOI: 10.1007/s11856-011-0173-7  0.055
1990 Raghavan D, Guay R, Torma AE. A study of biodegradation of polyethylene and biodesulfurization of rubber - Scientific note Applied Biochemistry and Biotechnology. 24: 387-396. DOI: 10.1007/BF02920262  0.055
1995 Raghavan D. Adjuvant systemic therapy of prostate cancer Seminars in Oncology. 22: 633-640. PMID 8539638  0.054
2024 Taur P, Kannan D, Penchala Reddy N, Raghavan D. Renal Hydatid Cyst: Diagnostic Quandaries and Surgical Strategies. Cureus. 16: e66289. PMID 39238698 DOI: 10.7759/cureus.66289  0.054
1992 Boyer M, Raghavan D. Toxicity of treatment of germ cell tumors Seminars in Oncology. 19: 128-142. PMID 1313191  0.053
1992 Grimmond SM, Raghavan D, Russell PJ. Detection of a rare point mutation in Ki-ras of a human bladder cancer xenograft by polymerase chain reaction and direct sequencing. Urological Research. 20: 121-6. PMID 1553789 DOI: 10.1007/BF00296523  0.053
2003 Raghavan D. Molecular targeting and pharmacogenomics in the management of advanced bladder cancer Cancer. 97: 2083-2089. PMID 12673700  0.053
1994 Boyer MJ, Raghavan D. Long-term morbidity of testicular cancer treatment Problems in Urology. 8: 154-166.  0.053
2010 Raghavan D. There is a van douwen mad family Transactions of the American Mathematical Society. 362: 5879-5891. DOI: 10.1090/S0002-9947-2010-04975-X  0.052
1996 Javle M, Raghavan D. Progress in the treatment of invasive bladder cancer Current Opinion in Urology. 6: 280-285.  0.052
1990 Torma AE, Raghavan D. Biodesulfurization of rubber materials American Society of Mechanical Engineers, Bioengineering Division (Publication) Bed. 16: 81-87.  0.052
2011 Chen C, Raghavan D. Thermally stable polymer nanocomposites Advances in Polymer Nanocomposite Technology. 175-198.  0.05
1993 Raghavan D, Wagner GC, Wool RP. Aerobic biometer analysis of glucose and starch biodegradation Journal of Environmental Polymer Degradation. 1: 203-211. DOI: 10.1007/BF01458028  0.05
1998 Javle M, Raghavan D. Radiotherapy and chemotherapy for invasive bladder cancer Cancer Surveys. 31: 149-160. PMID 15281322  0.05
2007 Raghavan D. Shri Arvind Lalbhai - The end of a glorious era Colourage. 54: 24+26.  0.049
2007 Raghavan D. Disparities in cancer care: Challenges and solutions Oncology. 21: 493-496. PMID 17474348  0.049
2008 Nargund VH, Raghavan D, Sandler HM. Urological oncology Urological Oncology. 1-634. DOI: 10.1007/978-1-84628-738-1  0.049
1997 Raghavan D, Koczwara B, Javle M. Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer European Journal of Cancer Part A. 33: 566-574. PMID 9274436 DOI: 10.1016/S0959-8049(96)00510-2  0.049
1991 Stockler M, Raghavan D. Neoplastic venous involvement and pulmonary embolism in patients with germ cell tumors Cancer. 68: 2633-2636. PMID 1657365  0.049
1979 Raghavan D, Murphy M. FATIGUE PROPERTIES OF 5456-H117 ALUMINUM ALLOY WELDMENTS Welding Journal (Miami, Fla). 58.  0.048
2001 Raghavan D, Emekalam A. Characterization of starch/polyethylene and starch/polyethylene/poly(lactic acid) composites Polymer Degradation and Stability. 72: 509-517. DOI: 10.1016/S0141-3910(01)00054-4  0.048
2012 Raghavan D, Shelah S. Comparing the closed almost disjointness and dominating numbers Fundamenta Mathematicae. 217: 73-81. DOI: 10.4064/Fm217-1-6  0.048
2020 T M, Raghavan D, Muthu R, Prabhakar V, Prakash S. Collecting duct carcinoma of kidney: Masquerading as genitourinary tuberculosis - Lessons learnt. Urology Case Reports. 29: 101100. PMID 31890601 DOI: 10.1016/j.eucr.2019.101100  0.047
2012 Raghavan D. Salvage or savage chemotherapy for poor-risk or relapsed testis cancer-20 years later, not much has changed Annals of Oncology. 23: 813-814. PMID 22172324 DOI: 10.1093/annonc/mdr556  0.047
2014 Raghavan D. Testis cancer: The forgotten poster child Clinical Cancer Research. 20: 3630-3631. PMID 24812412 DOI: 10.1158/1078-0432.CCR-14-0691  0.047
2000 Raghavan D. Study of rubber-filled cementitious composites Journal of Applied Polymer Science. 77: 934-942. DOI: 10.1002/(Sici)1097-4628(20000725)77:4<934::Aid-App30>3.0.Co;2-L  0.047
1994 Raghavan D, Tratt K, Wool RP. Recycled rubber in cement composites Materials Research Society Symposium - Proceedings. 344: 177-188. DOI: 10.1557/Proc-344-177  0.046
1995 Takita H, Blumenso LE, Raghavan D. Neoadjuvant chemotherapy of stage III-A and B lung carcinoma using the PACCO regimen Journal of Surgical Oncology. 59: 147-150. PMID 7609519 DOI: 10.1002/jso.2930590303  0.046
2006 Yim PJ, Vora AV, Raghavan D, Prasad R, McAullife M, Ohman-Strickland P, Nosher JL. Volumetric analysis of liver metastases in computed tomography with the fuzzy C-means algorithm. Journal of Computer Assisted Tomography. 30: 212-20. PMID 16628034 DOI: 10.1097/00004728-200603000-00008  0.045
2012 Raghavan D. Novel therapies for advanced prostate cancer: Have we have widened the goal posts too far? Annals of Oncology. 23: 2473-2475. PMID 22734010 DOI: 10.1093/annonc/mds185  0.045
2008 Kalmadi S, Raghavan D. Evolving perspectives of the role of novel agents in androgen-independent prostate cancer Indian Journal of Urology. 24: 303-308. DOI: 10.4103/0970-1591.42609  0.045
1997 Raghavan D. Management of invasive bladder cancer: Strategies of combined modality treatment Seminars in Radiation Oncology. 7: 37-44.  0.045
1996 Raghavan D. Are Voltaire and Rousseau now wrong? Lancet. 348: 17. PMID 8973495  0.044
2008 Raghavan D. Hormone-Refractory prostate cancer: A rational approach to chemotherapy Urological Oncology. 536-543. DOI: 10.1007/978-1-84628-738-1_31  0.042
2022 Selvaraj N, Pooleri GK, Addla SK, Raghavan D, Govindaswamy TG, Balakrishnan AK, Sivaraman A, Jain N, Kandasamy SG, Ragavan N. Robot assisted laparoscopic adrenalectomy: Should this be the new standard? Urologia. 3915603221097166. PMID 35634982 DOI: 10.1177/03915603221097166  0.042
1991 Raghavan D, Shaligram AM, Deshpande DD. Influence of charge density and steric factor of aminated chloromethyl polystyrene homologs in bilirubin adsorption Journal of Applied Polymer Science. 42: 2483-2488. DOI: 10.1002/app.1991.070420913  0.041
2008 Raghavan D. Prostate cancer: Too much dogma, not enough data Cleveland Clinic Journal of Medicine. 75: 33-34. PMID 18236727  0.041
2003 Balakrishnan S, Raghavan D. Mechanical properties of chemically functionalized clay vinyl ester nanocomposites Materials Research Society Symposium - Proceedings. 791: 261-263. DOI: 10.1557/Proc-791-Q8.13  0.041
2022 Thangarasu M, Prakash JS, Bafna S, Aarthy P, Govindaswamy TG, Venugopal B, Sivaraman A, Jain N, Balakrishnan A, Raghavan D, Venkatraman M, Chandranathan M, Paul R, Selvaraj N, Ramakrishnan B, et al. Influence of tumor size in the progression of venous tumor thrombus in renal cell carcinoma: A 7-year single-center experience. Urology Annals. 14: 273-278. PMID 36117789 DOI: 10.4103/UA.UA_169_20  0.041
2024 Kannan D, Thangarasu M, Paul R, Meenashi Sundaram P, Raghavan D. Peritoneal Window With Omental Interposition as a Prophylactic Measure to Prevent Post-Renal Transplant Lymphocele: A Pilot Study. Cureus. 16: e68406. PMID 39360085 DOI: 10.7759/cureus.68406  0.04
1991 Raghavan D, Chye RWM. Treatment of carcinomatous meningitis from transitional cell carcinoma of the bladder British Journal of Urology. 67: 438-440. PMID 2032089 DOI: 10.1111/j.1464-410X.1991.tb15178.x  0.04
2016 Raghavan D. Predicting Low Trial Accrual Mathematically: Is That the Right Emphasis? Journal of the National Cancer Institute. 108. PMID 26714556 DOI: 10.1093/jnci/djv379  0.039
2008 Raghavan D, Klein EA. Prostate cancer: moving forward by reinventing the wheel...but this time it is round. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 4535-6. PMID 18626003 DOI: 10.1200/JCO.2008.18.3145  0.039
2002 Feresenbet E, Raghavan D, Holmes GA. Application of self assembled monolayer approach to probe fiber matrix-adhesion Materials Research Society Symposium - Proceedings. 710: 167-172. DOI: 10.1557/Proc-710-Dd11.4.1/Aa10.4.1  0.039
1990 Raghavan D. Testis cancer: the way forward Progress in Clinical and Biological Research. 357: 235-243. PMID 2170993  0.037
1982 Raghavan D, Coates A, Friedlander M. Mitoxantrone (XAN): Progress in a phase ii trial in Sydney, Australia Proceedings of the American Society of Clinical Oncology 0.037
1988 Raghavan D. Pre-emptive (neo-adjuvant) intravenous chemotherapy for invasive bladder cancer British Journal of Urology. 61: 1-8. PMID 3277688 DOI: 10.1111/j.1464-410X.1988.tb09152.x  0.036
2003 Raghavan D. New prognostic factors for stage I testicular cancer: But will they make it to broadway? Journal of Clinical Oncology. 21: 4075-4076. PMID 14559887 DOI: 10.1200/JCO.2003.07.967  0.036
2013 Raghavan D. Cells, sieves, positive and negative attraction: But. slow progress in bladder cancer European Journal of Cancer. 49: 3065-3067. PMID 23845181 DOI: 10.1016/j.ejca.2013.06.007  0.035
2013 Lee TC, Raghavan D, Curtin HD. Image-guided percutaneous aspiration and gelfoam treatment of petrous apex cholesterol granuloma: a new theory and method for diagnosis and treatment. Journal of Neurological Surgery. Part B, Skull Base. 74: 342-6. PMID 24436935 DOI: 10.1055/s-0033-1345107  0.035
1996 Javle M, Raghavan D. Total androgen blockade for prostate cancer: the end does not justify the means Cancer Treatment and Research. 88: 201-210. PMID 9239481  0.035
2000 Raghavan D. 'Active surveillance' for stage I testis cancer: Attaining maturity at 21 years European Journal of Cancer. 36: 1891-1894. PMID 11000565 DOI: 10.1016/S0959-8049(00)00163-5  0.033
1993 Levine EG, Raghavan D. MVAC for bladder cancer: Time to move forward again Journal of Clinical Oncology. 11: 387-389. PMID 8445412 DOI: 10.1200/JCO.1993.11.3.387  0.033
2011 Raghavan D. Slow progress in cancer care disparities: HIPAA, PPACA, and CHEWBACCA... but were still not there! Oncologist. 16: 917-919. PMID 21804068 DOI: 10.1634/theoncologist.2011-0233  0.032
2016 Raghavan D. Cutaneous manifestations of genitourinary malignancy. Seminars in Oncology. 43: 347-52. PMID 27178687 DOI: 10.1053/j.seminoncol.2016.02.027  0.031
2013 Raghavan D. P-ideal dichotomy and weak squares Journal of Symbolic Logic. 78: 157-167. DOI: 10.2178/jsl.7801100  0.031
2008 Raghavan D. Chemicals and the Olympics! Colourage. 55: 30+32.  0.031
2013 Raghavan D. Remembering old lessons in prostate cancer: Avoiding errors 'in PARPituity' Oncology (United States). 27.  0.031
2013 Raghavan D. Remembering old lessons in prostate cancer: Avoiding errors 'in PARPituity' Oncology (United States). 27.  0.031
2013 Raghavan D. In germ cell cancer, are we at the end of the chemotherapy era? No-targeted therapies have not heralded its demise Oncology (United States). 27.  0.031
2013 Raghavan D. In germ cell cancer, are we at the end of the chemotherapy era? No-targeted therapies have not heralded its demise Oncology (United States). 27.  0.031
2014 Govindarajan N, Raghavan D. Doubly fed induction generator based wind turbine with adaptive neuro fuzzy inference system controller Asian Journal of Scientific Research. 7: 45-55. DOI: 10.3923/ajsr.2014.45.55  0.03
2020 Selvaraj N, Thangarasu M, Prakash S, Raghavan D, Khakhar A. Acquired post cesarean uretero-uterine fistula - a rare entity. Urology Case Reports. 33: 101314. PMID 33102016 DOI: 10.1016/j.eucr.2020.101314  0.03
2016 Raghavan D, Jain R. Increasing awareness of sex differences in airway diseases. Respirology (Carlton, Vic.). 21: 449-59. PMID 26677803 DOI: 10.1111/resp.12702  0.03
2004 Raghavan D. Chemotherapy for prostate cancer: Small steps or leaps and bounds? No huzzahs just yet! British Journal of Cancer. 91: 1003-1004. PMID 15475939 DOI: 10.1038/sj.bjc.6602157  0.029
2007 Raghavan D. A yawning "gap" in our understanding of business and social norms Colourage. 54: 28+30.  0.029
1999 Raghavan D. Prostate cancer management under scrutiny: One man's meta-analysis is another man's poisson Journal of Clinical Oncology. 17: 3371-3373. PMID 10550130  0.028
2011 Herliczek TW, Raghavan D, McCarten K, Wallach M. Sonographic upper gastrointestinal series in the vomiting infant: how we do it. Journal of Clinical Imaging Science. 1: 19. PMID 21966616 DOI: 10.4103/2156-7514.78528  0.028
1986 Grygiel J, Raghavan D. Clinical pharmacology and cancer chemotherapy an evolving interface? Medical Journal of Australia. 145: 458-463. PMID 3773833  0.028
1991 Levine EG, Raghavan D. Treatment of refractory testis cancer: Salvage or savage chemotherapy? European Journal of Cancer and Clinical Oncology. 27: 932-936. PMID 1657079 DOI: 10.1016/0277-5379(91)90150-C  0.028
2007 Raghavan D. A wealth of riches in RCC treatment: How do we avoid 'devaluing the dollar'? Oncology. 21: 1187+1190.  0.028
1997 Raghavan D. Prostate cancer, populations, politicians and power European Journal of Cancer (Oxford, England : 1990). 33: 329-330. PMID 9155513  0.028
1996 Raghavan D. Editorial: Perioperative chemotherapy for invasive bladder cancer - What should we tell our patients? Journal of Urology. 155: 1246-1247. PMID 8632541 DOI: 10.1016/S0022-5347(01)66231-1  0.028
2000 Abrha Y, Raghavan D. Polychlorinated biphenyl (PCB) recovery from spiked organic matrix using accelerated solvent extraction (ASE) and Soxhlet extraction Journal of Hazardous Materials. 80: 147-157. PMID 11080575 DOI: 10.1016/S0304-3894(00)00285-5  0.028
2007 Raghavan D. NPEO: The latest bad word in our industry Colourage. 54: 34+36.  0.028
1982 Monaghan P, Raghavan D, Neville AM. Ultrastructural studies of xenografted human germ cell tumors Cancer. 49: 683-697. PMID 6173110  0.028
1990 Raghavan D. Chemotherapy for advanced bladder cancer: ‘midsummer night’s dream’ or ‘much ado about nothing’? British Journal of Cancer. 62: 337-340. PMID 2206939 DOI: 10.1038/bjc.1990.293  0.027
2016 Raghavan D, Holley JL. Conservative Care of the Elderly CKD Patient: A Practical Guide. Advances in Chronic Kidney Disease. 23: 51-6. PMID 26709063 DOI: 10.1053/j.ackd.2015.08.003  0.027
1988 Raghavan D. Chemotherapy in the management of invasive and metastatic bladder cancer European Urology. 14: 21-23. PMID 3053200  0.027
2008 Rapuano BE, Boursiquot R, Tomin E, Macdonald DE, Maddula S, Raghavan D, Lane JM, Helfet DL. The effects of COX-1 and COX-2 inhibitors on prostaglandin synthesis and the formation of heterotopic bone in a rat model. Archives of Orthopaedic and Trauma Surgery. 128: 333-44. PMID 18034350 DOI: 10.1007/S00402-007-0436-2  0.027
1989 Raghavan D. Non-seminomatous testicular cancer, 1989: Primum non nocere Australian and New Zealand Journal of Surgery. 59: 103-104. PMID 2919994  0.026
1998 Raghavan D. Bladder preservation in patients with bladder cancer--quality versus quantity of life? The Journal of Urology. 160: 1678-1679. PMID 9783930  0.026
2012 Raghavan D. Introduction: Bladder cancer Seminars in Oncology. 39: 523. PMID 23040248 DOI: 10.1053/j.seminoncol.2012.08.002  0.025
2009 Raghavan D. India on the move.. European Coatings Journal. 10-13.  0.025
1993 Raghavan D. Chemotherapy for Bladder Cancer in the Elderly Drugs &Amp; Aging. 3: 1-8. PMID 8453182 DOI: 10.2165/00002512-199303010-00001  0.025
1999 Raghavan D. Editorial: Bladder preservation in patients with bladder cancer - Quality versus quantity of life? Journal of Urology. 160: 1678-1679. DOI: 10.1016/S0022-5347(01)62381-4  0.025
1995 Raghavan D. Characterization of biodegradable plastics Polymer-Plastics Technology and Engineering. 34: 41-63. DOI: 10.1080/03602559508017212  0.024
2012 Choueiri TK, Thakkar SG, Raghavan D. Adjuvant and neoadjuvant treatment for genitourinary cancers Principles and Practice of Surgical Oncology: a Multidisciplinary Approach to Difficult Problems 0.024
1981 Vogelzang NJ, Raghavan D, Savino D. Treatment of human testis cancer xenografts with a spermatocidal agent (win 18,446) Clinical Research. 29.  0.024
1985 Raghavan D. Current status and controversies in the management of genito-urinary cancer Australian and New Zealand Journal of Surgery. 55: 243-248. PMID 3863577  0.024
1984 Raghavan D. Expectant therapy for clinical stage A nonseminomatous germ-cell cancers of the testis? A qualified "Yes", World Journal of Urology. 2: 59-63. DOI: 10.1007/BF00326936  0.023
2000 Beer T, Raghavan D. Chemotherapy for hormone-refractory prostate cancer: Beauty is in the eye of the beholder Prostate. 45: 184-193. PMID 11027418 DOI: 10.1002/1097-0045(20001001)45:2<184::AID-PROS13>3.0.CO;2-K  0.023
1993 Russell PJ, Plomley J, Raghavan D. The use of monoclonal antibodies for the diagnosis and therapy of bladder cancer. British Journal of Urology. 71: 121-9. PMID 8461941  0.023
2003 Raghavan D. Testicular cancer: Maintaining the high cure rate Oncology. 17: 218-228.  0.022
2005 Raghavan D. The Renaissance clinician: Essential for the modern management of prostate cancer European Journal of Cancer. 41: 823-824. PMID 15808951 DOI: 10.1016/j.ejca.2005.02.003  0.022
2003 Raghavan D. Introduction: Perspectives in bladder cancer Cancer. 97: 2049. DOI: 10.1016/S0959-8049(98)00274-3  0.022
2013 Raghavan D. A structured approach to uncommon cancers: What should a clinician do? Annals of Oncology. 24: 2932-2934. PMID 24192449 DOI: 10.1093/annonc/mdt432  0.021
2005 Raghavan D. An eye on the future - India: One of the key markets in the coatings world European Coatings Journal. 16-17.  0.021
1998 Raghavan D. Editorial: Progress in management of advanced prostate cancer - Don't throw the baby out with the bath water Journal of Urology. 160: 1230-1231. PMID 9751324 DOI: 10.1016/S0022-5347(01)62502-3  0.02
2009 Raghavan D. Controversies in the management of localized prostate cancer: after the rhetoric Oncology (Williston Park, N.Y.). 23: 833-835. PMID 19839424  0.02
1990 Raghavan D, Wallace M. Preemptive (neoadjuvant) chemotherapy: Can analysis of eligibility criteria, prognostic factors, and tumor staging from different trials provide valid or useful comparisons? Seminars in Oncology. 17: 613-618. PMID 2218574  0.02
1990 Russell PJ, O'Mara SM, Raghavan D. Ectopic hormone production by small cell undifferentiated carcinomas. Molecular and Cellular Endocrinology. 71: 1-12. PMID 2163929 DOI: 10.1016/0303-7207(90)90068-J  0.019
2012 Raghavan D, Boxerman J, Rogg J, Cosgrove R. Glioblastoma multiforme: utilization of advanced MRI techniques for preoperative planning. Medicine and Health, Rhode Island. 95: 42-3. PMID 22474872  0.019
2013 Raghavan D. Testis cancer: On gilding the lily Annals of Oncology. 24: 269-270. PMID 23243194 DOI: 10.1093/annonc/mds611  0.019
2006 Raghavan D, Liu H, Stubbs J. Evaluation of biological responses of UMR-106 cells to porous PHBV matrix Materials Research Society Symposium Proceedings. 950: 136-141.  0.018
2006 Raghavan D, Suh T. Cancer in the elderly population: The protection racket Journal of Clinical Oncology. 24: 1795-1796. PMID 16567764 DOI: 10.1200/JCO.2005.05.4502  0.017
2007 Raghavan D. Dedicated addressal of machinery in COLOURAGE Colourage. 54: 28+30.  0.016
2013 Raghavan D. PSA: Please stop agonizing (over prostate- specific antigen interpretation) Mayo Clinic Proceedings. 88: 1-3. DOI: 10.1016/j.mayocp.2012.11.004  0.016
2013 Raghavan D. Costs of cancer care: Rhetoric, value, and steps forward Seminars in Oncology. 40: 659-661. PMID 24331187 DOI: 10.1053/j.seminoncol.2013.10.001  0.016
1998 Raghavan D. Managed care did not contribute to the development of curative treatment of germ cell tumors The Journal of Urology. 160: 1970. PMID 9817301  0.015
2004 Balakrishnan S, Raghavan D. Acrylic, elastomeric, particle-dispersed epoxy-clay hybrid nanocomposites: Mechanical properties Macromolecular Rapid Communications. 25: 481-485. DOI: 10.1002/Marc.200300111  0.015
2006 Raghavan D. Cotton: Indian textile industry's trump card Colourage. 53.  0.015
2006 Raghavan D. An essay on rearranging the deck chairs: What's wrong with the cancer trials system? Commentary on Gray et al., p. 1966 Clinical Cancer Research. 12: 1949-1950. PMID 16608999 DOI: 10.1158/1078-0432.CCR-06-0424  0.014
1990 Raghavan D, Boyer M. Active surveillance for stage I non-seminomatous germ cell testis tumors: practice and pitfalls Progress in Clinical and Biological Research. 350: 309-318. PMID 2166960  0.013
1993 Jones VE, Raghavan D. Quantum leaps in treatment of high-risk breast cancer? Prove it! European Journal of Cancer. 29: 1488-1493. PMID 8398281 DOI: 10.1016/0959-8049(93)90027-D  0.013
2015 Raghavan D. Choosing wisely: Where's the beef? Journal of Oncology Practice. 11: 325-326. DOI: 10.1200/JOP.2015.004663  0.013
2007 Raghavan D. Finishing ... The beginning of a healthy profitability Colourage. 54: 26+28.  0.012
2006 Raghavan D. TUF(S) to comprehend! Colourage. 53.  0.012
1991 Raghavan D. Clinician surrogates and equipoise: An analogy to lawyers who represent themselves? European Journal of Cancer and Clinical Oncology. 27: 1072-1074. PMID 1835615 DOI: 10.1016/0277-5379(91)90294-N  0.011
1980 Raghavan D, Jelihovsky T, Fox RM. Father-son testicular malignancy. Does genetic anticipation occur? Cancer. 45: 1005-1009. PMID 7260832  0.011
2015 Nargund VH, Raghavan D, Sandler HM. Preface to first edition Urological Oncology. vii. DOI: 10.1007/978-0-85729-482-1  0.01
2012 Raghavan D, Boxerman J, Jeyapalan S, Rogg J. Radiation necrosis of a high-grade glioma. Medicine and Health, Rhode Island. 95: 159-60. PMID 22808637  0.01
2008 Raghavan D. Where the demand always exceeds the supply.. Colourage. 55: 30+32.  0.01
2007 Raghavan D. Investments and the risk factor Colourage. 54: 20+22.  0.01
2007 Raghavan D. "P" for death? Colourage. 54: 26+28.  0.01
2007 Raghavan D. Co-branding - Tapping latent synergies Colourage. 54: 34+36.  0.01
2006 Raghavan D. Indian Labour Law changes - Almoszt there, but not quite.. Colourage. 53.  0.01
2006 Raghavan D. Mumbai textile mills: The fall of the last bastion? Colourage. 53: 38+40.  0.01
2006 Raghavan D. Blame it on DMAI!!! Colourage. 53.  0.01
2006 Raghavan D. Acceptability through Eco-Labelling in our textile industry Colourage. 53.  0.01
2005 Raghavan D. Hidden by HIPAA: The costs of cure Journal of Clinical Oncology. 23: 3663-3665. PMID 15738543 DOI: 10.1200/JCO.2005.11.951  0.01
2004 Tesema Y, Raghavan D, Stubbs J. A comparative study of bone cell viability on collagen immobilized porous and non-porous poly(hydroxl) butyrate films Materials Research Society Symposium Proceedings. 61-63.  0.01
1993 Raghavan D. Active surveillance for stage I testis cancer: Two steps forward one step back European Urology. 23: 49. PMID 8390361  0.01
1977 Collett P, Raghavan D, Salasoo S. Successful treatment of methotrexate-induced renal failure by haemodialysis Australian and New Zealand Journal of Medicine. 7: 441.  0.01
Hide low-probability matches.